Price $3.43 |
Market Cap
296.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
37.79
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-69.9K
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
416.80%
|
ROI
203.20%
|
|
ROA
-120.30%
|
EPS Growth
-102.60%
|
Current Ratio
12.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pacific Biosciences of Califor (PACB) | $5.61 | - | - | 581.8M | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.33 | - | - | 25.2M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.62 | - | - | 122M | Strong Buy |
| Advanz Pharma Corp Ltd (CXRXF) | $4.02 | - | - | 159M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.38 | - | - | 48.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
